Prescription drug costs are already a major concern, especially if you rely on long-term medications. Trump's tariffs could worsen the problem by increasing prices on certain drugs manufactured outside the U.S., which could affect your retirement plan.
The policy introduced steep tariffs on imported pharmaceuticals, doubling the prices for some affected medications.
Here's what's happening, how it could impact what you pay at the pharmacy, and how you can prepare yourself financially.
Editor's note: Prices and availability are subject to change and may vary by location.
Now Available: The Definitive Guide to Retirement Income
Many successful investors eventually reach the same moment. The saving is done, the portfolio is built, and the question quietly changes from how much can I grow this to how much can I take out? Get that second question wrong and decades of good investing can come apart in a handful of years.
That is exactly what The Definitive Guide to Retirement Income helps answer.1 <p class="">Investing in securities involves a risk of loss. Past performance is never a guarantee of future returns. Investing in foreign stock markets involves additional risks, such as the risk of currency fluctuations. Guides are provided by Fisher Investments. The publisher may be compensated when readers request a guide.</p> It covers what your retirement could actually cost, which income sources are worth using, and the withdrawal math that decides whether the money lasts. It is free today from Fisher Investments. Read More Here ›
The pharmaceutical tariffs explained
On July 31, 2026, the Trump administration imposed a 100% tariff on many imported patented drugs and their key ingredients. 17 named companies were given a very brief opportunity to negotiate U.S.-based manufacturing or pricing agreements to avoid the penalty. Those who comply may reduce or eliminate the tariff.
Generics and biosimilars remain exempt until July 31, 2028, but the policy could raise immediate costs for patients relying on brand-name medications.
Which drugs could see prices double?
Popular examples include Entresto for heart failure and Lenvima for certain cancers.
Without insurance, a month's supply of some of these could jump by hundreds or even thousands of dollars once the tariff hits the supply chain.
Entresto could cost you twice as much
Entresto is a widely prescribed heart failure medication that currently costs between $888.71 and $969.00 for 60 tablets without insurance. A 100% tariff could push that price to between $1,777 and $1,938. Since it's often used as a first-line treatment, demand remains steady.
If pharmacies pass on the increase, even insured patients may face higher copays or coinsurance, putting added pressure on monthly budgets.
Released: The Definitive Guide to Retirement Income (Sponsor)
Most people spend their entire working lives focusing on one thing: growing a pile of money. Then they retire and discover the skill they actually need is close to the opposite. Turning that pile into steady income, year after year, through good markets and bad, without ever running out. It may be the least discussed and most consequential transition in personal finance, and plenty of otherwise careful investors walk into it with no real plan.
That is exactly what The Definitive Guide to Retirement Income helps answer.1 <p class="">Investing in securities involves a risk of loss. Past performance is never a guarantee of future returns. Investing in foreign stock markets involves additional risks, such as the risk of currency fluctuations. Guides are provided by Fisher Investments. The publisher may be compensated when readers request a guide.</p> It is a free guide from Fisher Investments covering what your retirement will really cost, where the cash flow should come from, and how much you can safely withdraw each year. Learn More Here ›
Keytruda negotiated to avoid tariffs
Keytruda, a leading cancer immunotherapy manufactured in Ireland, costs around $6,000.54 per dose without insurance. Its manufacturer, Merck, secured a three-year tariff exemption by agreeing to Most-Favored-Nation (MFN) drug pricing for American patients and implementing domestic operations incentives.
Other oncology drugs made abroad face tariff pressure. Cancer patients often have limited alternatives, so higher prices create serious access problems even for those with good insurance coverage.
Ozempic and Wegovy negotiated to avoid tariffs
These popular GLP-1 drugs for diabetes and weight loss currently cost over $1,000 per month without insurance. However, Novo Nordisk secured a HHS Most-Favored-Nation (MFN) drug-pricing agreement and a Department of Commerce onshoring agreement to move production to the U.S., avoiding the tariffs.
Why brand-name drugs get hit hardest
Tariffs apply only to patented medications and their ingredients, not generics, for now. Brand-name drugs carry high list prices and complex international supply chains.
Generics make up over 90% of prescriptions filled in the U.S., according to the Association for Accessible Medicines. These are currently set to stay exempt through July 31, 2028. This creates a bigger burden on patients who need newer or specialty treatments without generic options yet.
The case for tariffs from supporters
Supporters argue that these tariffs are going to force companies to build U.S. factories and lower prices through most-favored-nation deals. Bringing manufacturing home reduces reliance on foreign supply chains and could create American jobs.
In the long run, they say increased competition and domestic production could drive prices down and improve national security for critical medicines.
Critics warn of short-term pain
Critics argue the policy could raise drug costs quickly, long before any new U.S. manufacturing facilities open. In the meantime, patients may face higher out-of-pocket costs, which could lead some to delay or skip essential treatments.
Supply disruptions also remain possible during the transition. Experts worry that higher prices are going to increase insurance premiums and strain Medicare and Medicaid budgets, ultimately costing taxpayers more.
How insurance may or may not protect you
Many plans could absorb part of the increase, but you would likely feel it through higher premiums, larger copays, or restricted formularies. Medicare Part D plans may shift more costs to you in the coverage gap. Some employer plans could raise deductibles.
Cash-pay patients and those with high-deductible plans face the full impact immediately. The tier your medication is placed under determines how much your out-of-pocket cost is likely to be.
Earn $100 cash rewards bonus with this incredible card
The Wells Fargo Active Cash® Card (Rates and fees) has no annual fee and you can earn a $100 cash rewards bonus after spending $500 in purchases in the first 3 months.
Cardholders can also earn unlimited 2% cash rewards on purchases.
The best part? There's no annual fee.
What this means for you
If you rely on prescription medications, especially brand-name drugs made overseas, these tariffs could translate directly into higher out-of-pocket costs. You may see increased copays, higher coinsurance, or rising premiums as insurers adjust to the new pricing.
The impact tends to be more immediate for ongoing treatments, where switching isn't always possible. Even if your plan covers the drug, higher list prices could still affect what you pay over time.
Steps to take to lower your costs
Even small moves now could help you avoid bigger price increases later, before new pricing takes effect.
- Talk to your doctor about switching to generics or biosimilars where possible.
- Check your insurance formulary for covered alternatives.
- Use discount programs if available for your medications.
Taking action early could help you stay ahead of rising costs and keep your treatment plan manageable.
Bottom line
Tariffs on pharmaceuticals could quickly reshape drug pricing, especially in the short term. While the policy aims to encourage domestic production, the immediate effect may be higher costs for many commonly used medications.
If you're affected, acting early could help you keep more of your money. Check platforms like TrumpRx.gov and manufacturer assistance programs, which may offer lower pricing or temporary relief during the transition period.
More from FinanceBuzz:
- Retire like the rich: 14 ways you could build wealth in your 50s.
- Find out if you could pay less for car insurance in just a few clicks.
- Make these 7 savvy moves when you have $1,000 in the bank.
- 14 moves seniors could benefit from but often forget about.
Add Us On Google